Chief Executive Officer & President @ Vero Biotech
President & CBO @ Cardiorentis
The Medicines Company @
Bachelor's Degree @
Kennesaw State University
Exceptional Business Builder, Revenue Capture, & Operational Expert with a distinguished career and demonstrated success developing and maximizing profitability and building or restoring market share in highly complex and competitive business climates both domestically and internationally. Widely considered a key strategic player and regularly called upon by stakeholders to provide thought leadership in the creation, development, and
Exceptional Business Builder, Revenue Capture, & Operational Expert with a distinguished career and demonstrated success developing and maximizing profitability and building or restoring market share in highly complex and competitive business climates both domestically and internationally. Widely considered a key strategic player and regularly called upon by stakeholders to provide thought leadership in the creation, development, and implementation of mission-critical, initiatives with global implications. Proven capacity to attract, recruit, mentor, manage, and retain productive teams and lead them in the execution of strategic initiatives that are key-to-the-mission in both stable and unstable environments. Tenacious at developing new revenue opportunities, securing customer loyalty, and forging long term relationships with external and internal business partners that fortify, drive, and sustain Shareholder value.
ACHIEVEMENT CATEGORIES REPRESENTED BELOW
• Leadership • Partnership Development • Revenue Growth Strategies • Joint Ventures
• Operational Excellence • Global Market Penetration • Strategic Alliance Development
• Mergers & Acquisitions • Team Building • Revenue Optimization • Global Sales Strategy • Restructure
Chief Customer Officer & Executive Vice President @ THE MEDICINES COMPANY CORPORATE PROFILE: MDCO is a global company (~$1.75B market cap with 650 employees) and is focused serving the 3,000 leading acute/intensive care hospitals worldwide; providing solutions in three categories: Acute Cardiovascular, Surgery and Perioperative and Serious Infectious Disease Care.
RESPONSIBILITY PROFILE: Joined company pre-IPO, recruited by the CEO and commissioned to grow the business with full P&L and manage up to. Led 350 employees and established sales trajectory in 120 days while personally closing major accounts. Achieved 46% CAGR over 14 years.
ACHIEVED IN THIS ROLE:
• SALES DEVELOPMENT: Recruited and mentored 110 representatives. Created and led a multipronged market penetration strategy; targeted, approached, presented, and closed multiple accounts; achieving desired momentum the first year.
• EMPLOYEE ENGAGEMENT: Communicated unified purpose, mission, and goals. This achieved camaraderie and delivered consistent employee performance, which eased recruiting, grew customer satisfaction, revenue, and trust. Maintained 97% Aligned, Capable and Engaged (ACE Scores).
• PARTNERSHIP / STRATEGIC ALLIANCE DEVELOPMENT: For expansion, conceived and initiated a multiyear deal with AstraZeneca (AZ). Within 2 years, AZ eclipsed their primary competitor while exponentially increasing profit for MDCO.
• REVENUE OPTIMIZATION: Established sales and costs optimization strategy that brought about a cultural paradigm shift in the sales team and within a year, achieved cost reductions and 15 consecutive Quarters of growth providing cash flow to enable acquisition and development of new products.
• JOINT VENTURE: Conceived a partnership to co-promote best products of the medical device industry. Presented and received approval from the Board to partner with Boston Scientific, negotiated and closed the deal within 30 days. This was the first device | pharmaceutical company joint venture among the industry. From 2000 to 2015 (15 years) Senior Vice President & Chief Customer Officer @ RESPONSIBILITY PROFILE Responsibilities similar to current role with ever expanding product portfolio and serves as Section 16 Officer, lead all business operations; product strategy, customer engagement, pricing strategy, Research & Development, Manufacturing & Partnerships. From 2009 to 2013 (4 years) Senior Vice President & General Manager Surgery and Perioperative Business @ RESPONSIBILITY PROFILE: Report to CEO with full P&L, 85 employees with 15 direct. Challenged to takeover, lead, and manage a new business; product strategy, customer engagement, pricing strategy, Research & Development, Manufacturing & Partnerships. From 2008 to 2009 (1 year) Vice President of Global Scientific Affairs and Strategic Development @ RESPONSIBILITY PROFILE: Global P&L (26 countries with $15M budget, 36 employees with 6 direct) reporting to COO. Lead all health science engagement strategies, compliance, partnerships, and health science support services. From 2005 to 2008 (3 years) Vice President and General Manager Cardiovascular Business @ RESPONSIBILITY PROFILE: Global P&L ($350M, 135 employees with 15 direct) reporting to CEO. Lead operations, product strategy & acquisitions, customer engagement, pricing, R&D, and Manufacturing for the Cardiovascular Business. From 2004 to 2005 (1 year) Vice President of Sales & Marketing @ RESPONSIBILITY PROFILE: Report to CEO, full P&L ($200m) and responsibility for 100 employees with 12 direct. Lead all sales, marketing, education, partnerships and strategy development for Angiomax; launch, culture, brand and product strategy.
ACHIEVED IN THIS ROLE
• PRODUCT LAUNCH: MDCO had only product; Angiomax so the Board and all leadership knew a proper launch would be paramount to survival. Despite limited resources and a lack of corporate reputation, built a team (65), strategy, and obtained buy-in globally by personally winning accounts from Merck, SPC, and generics. This redefined product launch strategy has become the model at MDCO. From 2001 to 2004 (3 years) Regional Business Director, South East Region @ RESPONSIBILITY PROFILE: Report to VP of Sales responsible for all sales in the 15 states covering the South East and Mid-Atlantic US as well as product launch strategy, recruitment, building a team of 15 sales professionals and building a acute cardiovascular business. From 2000 to 2001 (1 year) Medical Center Manager, Schering-Plough Corporation @ CORPORATE PROFILE: Merck is a global healthcare company with 71,000 employees that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and consumer and animal health products.
RESPONSIBILITY PROFILE: Managed the business for the launch of Acute Care Cardiovascular (Cath Lab) product, Integrilin covering all major Hospitals in Western North Carolina. From 1999 to 2000 (1 year) U.S. Cardiovascular Division | Area Business Manager (Pravachol – lipid business) @ CORPORATE PROFILE: Bristol Myers Squibb Corporation mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
RESPONSIBILITY PROFILE: Managed the business for Western North Carolina and South Carolina, covering hospitals and key cardiovascular clinics. From 1997 to 1999 (2 years) District Sales Representative & Director of Marketing Pierce, Young and Angel - Monarch, Inc., @ CORPORATE PROFILE: Pierce, Young and Angel - Monarch, Inc., was acquired by Sara Lee Foodservice which is now a division of Hillshire Brands which began trading under the “HSH” ticker symbol on June 29, 2012, following the successful spinoff of its international coffee and tea business. For more information about Hillshire Brands, please visit www.hillshirebrands.com.
RESPONSIBILITY PROFILE: Responsible for employees to provide sales and marketing leadership for the Atlanta market covering 25 accounts and to build all marketing strategy for the Latin American market. From 1997 to 1997 (less than a year) Peoria, Illinois AreaChief Financial Officer, Finance & Operations, National Center for Chronic Disease @ CORPORATE PROFILE: The CDC works to protect America from health, safety and security threats, both foreign and in the U.S. Whether chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease.
NATIONAL CENTER FOR CHRONIC DISEASE CORPORATE PROFILE: Chronic diseases and conditions—such as heart disease, stroke, cancer, diabetes, obesity, and arthritis—are among the most common, costly, and preventable of all health problems.
CHIEF FINANCIAL OFFICER RESPONSIBILITY PROFILE: Responsible for 15 employees with 7 direct and a $450M budget. Manage all business operations and budget management for the Chronic Disease Center of the National CDC. This included all general and administrative expenses, contracts and globally awarded grants. From 1990 to 1996 (6 years) Greater Atlanta Area
Master of Business Administration (M.B.A.), International Buisness, Magna Cum Laude @ Mercer UniversityBachelor's Degree, Liberal Arts and Sciences/Liberal Studies @ Kennesaw State University Brent Furse is skilled in: Leadership, Strategy, Sales Effectiveness, Revenue Growth Strategies, Product Launch, Revenue Optimization, Acquisition Integration, Strategic Planning, International Joint Ventures, Commercialization, Operational Excellence, Sales Operations, Mergers & Acquisitions, Business Scale-up, Global Sales Strategy